Intrua Financial LLC Cuts Stock Holdings in CVS Health Corporation $CVS

Intrua Financial LLC lessened its stake in CVS Health Corporation (NYSE:CVS) by 14.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,373 shares of the pharmacy operator’s stock after selling 1,200 shares during the quarter. Intrua Financial LLC’s holdings in CVS Health were worth $509,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Schwarz Dygos Wheeler Investment Advisors LLC increased its stake in CVS Health by 17.9% during the second quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 11,561 shares of the pharmacy operator’s stock worth $798,000 after acquiring an additional 1,753 shares during the last quarter. Fiera Capital Corp grew its holdings in shares of CVS Health by 17.2% during the 2nd quarter. Fiera Capital Corp now owns 4,771 shares of the pharmacy operator’s stock worth $329,000 after purchasing an additional 701 shares during the period. Thompson Davis & CO. Inc. acquired a new stake in CVS Health during the 2nd quarter worth approximately $1,140,000. ABN Amro Investment Solutions purchased a new position in CVS Health in the second quarter valued at approximately $890,000. Finally, Police & Firemen s Retirement System of New Jersey lifted its position in CVS Health by 3.4% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 190,209 shares of the pharmacy operator’s stock valued at $13,121,000 after buying an additional 6,342 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS opened at $77.86 on Friday. The company has a market capitalization of $98.84 billion, a P/E ratio of 204.90, a PEG ratio of 0.87 and a beta of 0.60. The company has a 50-day moving average of $77.70 and a 200-day moving average of $69.90. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research reports. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Wolfe Research raised their price objective on CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Monday, September 22nd. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Sanford C. Bernstein raised their target price on CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Finally, The Goldman Sachs Group assumed coverage on CVS Health in a report on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $89.41.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.